Gastrointestinal Cancer

Pathologists and laboratory professionals are key members of the multidisciplinary cancer care team, with roles in the diagnosis, testing, and management of diseases such as gastrointestinal cancer. As new evidence continues to emerge related to personalized testing, treatment, and reporting, ASCP is dedicated to helping you stay abreast of new findings to ensure accurate diagnoses and improve the standard of care for patients with gastrointestinal cancer.

Jump to a specific activity

Diagnostic Pitfalls and Challenges in Hepatocellular Carcinoma

This one-hour CME/CMLE credit-bearing case-based online module will provide the latest guidance to the laboratory team in providing the most accurate recommendations for testing as members of the multidisciplinary hepatocellular carcinoma (HCC) cancer treatment team.

This activity addresses the following topics:

  • Liver tissue acquisition
  • HCC diagnostic challenges
  • IHC and ISH staining techniques to resolve common differential diagnoses
  • HCC biomarkers

Faculty

Jingmei Lin, MD, PhD, FASCP, Professor and Director of GI and Liver Pathology, Department of Pathology and Laboratory Medicine, Indiana University

Rondell P. Graham, MBBS, Professor of Lab Medicine and Pathology, Head of Section of GI/Liver Pathology, Vice Chair of Test Development for the Department of Lab Medicine and Pathology, Mayo Clinic

Topics

hepatocellular carcinoma; gastrointestinal cancer

Online Module

Diagnostic Pitfalls and Challenges in Hepatocellular Carcinoma

This project is provided by an independent educational grant from Pfizer.

View on YouTube

Multidisciplinary Approach to Diagnosis and Biomarker Testing in Gastrointestinal Cancer

Recorded February 15, 2022

This 60-minute on-demand webcast highlights practice-changing developments in gastrointestinal biomarker testing and treatment, including new clinical data with immediate implications for patient care. Using a case-based approach, an expert GI pathologist and oncologist will help you learn optimal testing, interpreting findings, individualized treatment, and sequencing strategies for gastrointestinal cancers.

Topics include:

  • Biomarkers and the use of molecular testing to guide therapy selection in patients with advanced colorectal, pancreatic, biliary, gastric, esophageal, and gastroesophageal junction cancers, such as:
    • BRAF V600E, BRCA1/2, HER2/HER3, BRAF V600E, IDH1, and FGFR2
    • Tumor agnostic biomarkers, such as MMR/MSI, NTRK, and TMB
    • Emerging biomarkers
  • Emerging assays in GI cancers, such as liquid biopsy

Faculty

Wei Jiang, MD, PhD, FASCP, Associate Professor, Director, Translational Research/Pathology Shared Resource of Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

Atrayee Basu-Mallick, MD, Associate Professor, Medical Oncology, Jefferson Health/Jefferson University Hospitals, Philadelphia, PA

Topics

Gastrointestinal Cancer

Multidisciplinary Approach to Diagnosis and Biomarker Testing in Gastrointestinal Cancer

Provided by American Society of Clinical Pathology in partnership with Clinical Care Options, LLC. Supported by independent educational grants from Pfizer Inc. and Seagen Inc.
Download Slideset (ppt)